Fibrosis is a deadly thread winding through scores of fatal diseases. To jump-start better fibrosis understanding and groundbreaking research, UVA Professor Thomas H. Barker has launched the Fibrosis Initiative, a Grounds-wide effort.
Led by UVA professor Jeffrey W. Holmes, PhD, MD, who holds dual appoints in Biomedical Engineering and Medicine, the initiative encourages collaboration between engineers and clinicians.
Excess scarring, or fibrosis, is implicated in dozens of conditions. UVA researchers are working together to discover more effective treatments.
Researchers at the University of Virginia School of Medicine have received more than $8.6 million in federal grants to support cutting-edge projects being conducted by UVA’s Victor E. Laubach, Dr. Irving Kron and their colleagues
Using a new $1.5 million grant, University of Virginia researchers are embarking on an ambitious study, using innovative laboratory techniques, to delve into the working of the heart’s scaffolding.
Big data is involved with most aspects of research these days, according to Francis S. Collins, director of the National Institutes of Health, who spoke on October 11th at the University of Virginia’s Old Cabell Hall.
University of Virginia biomedical engineers and physicians have earned a role in a new, national initiative that will develop technologies for manufacturing human tissues and organs, with the goal of making them readily available to patients.
A research team led by Dr. Thomas J. Braciale has found that two drugs used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 percent of people who contract it.
Dr. Okusa will lead an organization of nearly 17,000 health professionals dedicated to leading the fight against kidney diseases.
A company started by a Department of Biomedical Engineering professor Kimberly Kelly is developing a drug with the potential to treat multiple cancers without the severe side effects of chemotherapy
A team from the University of Virginia School of Medicine has developed a quicker way to examine the impact of gene mutation on patient health, potentially changing the way cancer labs conduct research into precision medicine and personalized therapies.
The Pulmonary Fibrosis Foundation has selected University of Virginia Health System to join the foundation’s PFF Care Center Network. As part of the PFF Care Center Network, UVA will collaborate with 39 other sites making up the Network across the country to advance the care of people living with pulmonary fibrosis.